99% Savings - Buy Just @1 Rs X
Oncotar 500 Injection 5 Ml is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Breast Cancer.
Medical history of the patient along with age and gender determines the dosage of Oncotar 500 Injection 5 Ml. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Oncotar 500 Injection 5 Ml have been listed ahead. Usually, these side effects of Oncotar 500 Injection 5 Ml go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Oncotar 500 Injection 5 Ml has a Severe effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Oncotar 500 Injection 5 Ml has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Oncotar 500 Injection 5 Ml related warnings section.
Other contraindications of Oncotar 500 Injection 5 Ml have been discussed in the sections ahead.
Drug reaction of Oncotar 500 Injection 5 Ml with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Oncotar 500 Injection 5 Ml, it is important to know that it is not safe while driving, and is not habit-forming.
Oncotar 500 Injection 5 Ml is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Oncotar 500 Injection 5 Ml safe for pregnant women?
Oncotar shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Oncotar 500 Injection 5 Ml safe during breastfeeding?
Oncotar can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Oncotar 500 Injection 5 Ml on the Kidneys?
Oncotar rarely affects the kidneys.
What is the effect of Oncotar 500 Injection 5 Ml on the Liver?
Oncotar may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Oncotar 500 Injection 5 Ml on the Heart?
Side effects of Oncotar rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Oncotar 500 Injection 5 Ml unless your doctor advises you to do so -
Is this Oncotar 500 Injection 5 Ml habit forming or addictive?
No, you will not get addicted to Oncotar 500 Injection 5 Ml.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Oncotar 500 Injection 5 Ml can make you feel drowsy.
Is it safe?
Oncotar 500 Injection 5 Ml should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Oncotar 500 Injection 5 Ml is not used to treat mental disorders.
Interaction between Food and Oncotar 500 Injection 5 Ml
There is no information on the effects of taking Oncotar 500 Injection 5 Ml with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Oncotar 500 Injection 5 Ml
It is difficult to say anything about the effect of Oncotar 500 Injection 5 Ml and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Soltamox® (tamoxifen citrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 313-314
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1171-1172